Company & Sponsor Intelligence
The Hospital for Sick Children
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting2
Completed4
Countries2
Therapeutic footprint
depressionepilepsymultiple_sclerosisother_neurology
Indexed studies
NCT02458846Efficacy of Visual Screening in Ontario
other_neurology · CanadaNA
other_neurology · CanadaNA
NCT02983695Cannabinoid Therapy for Pediatric Epilepsy
epilepsy · CanadaPHASE1
epilepsy · CanadaPHASE1
NCT03831425Mitochondrial Complex I Dysfunction in PWS
other_neurology · CanadaPHASE2
other_neurology · CanadaPHASE2
NCT01161108Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities
epilepsy · CanadaPHASE3
epilepsy · CanadaPHASE3
NCT04782466ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research Program
multiple_sclerosis · United StatesNA
multiple_sclerosis · United StatesNA
NCT07010276Deep Brain Stimulation vs. Vagus Nerve Stimulation for Epileptic Spasms
epilepsy · CanadaNA
epilepsy · CanadaNA
NCT06175052A Personalized Nutrition Intervention for Adolescent Depression
depression · CanadaNA
depression · CanadaNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →